|
![Return to Home Page](/common/images/FTPlogo.jpg) |
|
Total Number of Holdings (excluding cash): 50
Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
48,392 |
$1,460,470.56 |
7.81% |
AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
7,299 |
$1,329,658.83 |
7.11% |
Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
7,963 |
$1,271,213.32 |
6.80% |
Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
10,107 |
$1,271,965.95 |
6.80% |
Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
25,327 |
$1,146,553.29 |
6.13% |
United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
2,580 |
$867,834.60 |
4.64% |
Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
2,346 |
$784,267.80 |
4.19% |
Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
1,528 |
$752,173.28 |
4.02% |
Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
665 |
$707,686.35 |
3.79% |
Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
852 |
$699,653.88 |
3.74% |
Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
8,912 |
$681,857.12 |
3.65% |
Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
2,961 |
$673,449.84 |
3.60% |
Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
51,954 |
$610,979.04 |
3.27% |
Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
3,240 |
$585,662.40 |
3.13% |
Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals |
25,438 |
$561,416.66 |
3.00% |
Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
5,739 |
$556,166.49 |
2.97% |
Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
4,742 |
$519,438.68 |
2.78% |
Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
1,507 |
$334,267.67 |
1.79% |
Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
5,558 |
$311,081.26 |
1.66% |
Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
645 |
$245,422.50 |
1.31% |
Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
8,228 |
$230,959.96 |
1.24% |
Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
3,091 |
$211,949.87 |
1.13% |
Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
6,716 |
$188,316.64 |
1.01% |
Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
1,115 |
$162,901.50 |
0.87% |
Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
7,005 |
$160,834.80 |
0.86% |
Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
2,027 |
$142,700.80 |
0.76% |
Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
563 |
$118,618.47 |
0.63% |
Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
8,935 |
$114,546.70 |
0.61% |
Blueprint Medicines Corporation |
BPMC |
09627Y109 |
Pharmaceuticals |
959 |
$109,028.71 |
0.58% |
Intra-Cellular Therapies, Inc. |
ITCI |
46116X101 |
Biotechnology |
1,292 |
$104,445.28 |
0.56% |
TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
5,212 |
$104,135.76 |
0.56% |
Arcellx, Inc. |
ACLX |
03940C100 |
Biotechnology |
1,631 |
$102,247.39 |
0.55% |
Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals |
1,985 |
$102,942.10 |
0.55% |
Rhythm Pharmaceuticals, Inc. |
RYTM |
76243J105 |
Biotechnology |
2,067 |
$102,543.87 |
0.55% |
Sarepta Therapeutics, Inc. |
SRPT |
803607100 |
Biotechnology |
702 |
$103,587.12 |
0.55% |
Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
859 |
$100,760.70 |
0.54% |
Merus NV |
MRUS |
N5749R100 |
Biotechnology |
1,852 |
$100,600.64 |
0.54% |
Kymera Therapeutics, Inc. |
KYMR |
501575104 |
Biotechnology |
2,101 |
$92,528.04 |
0.49% |
BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
1,040 |
$89,013.60 |
0.48% |
Nuvalent, Inc. (Class A) |
NUVL |
670703107 |
Biotechnology |
1,067 |
$85,306.65 |
0.46% |
IDEAYA Biosciences, Inc. |
IDYA |
45166A102 |
Biotechnology |
2,009 |
$84,960.61 |
0.45% |
MoonLake Immunotherapeutics (Class A) |
MLTX |
61559X104 |
Biotechnology |
1,861 |
$83,577.51 |
0.45% |
Roivant Sciences Ltd. |
ROIV |
G76279101 |
Biotechnology |
7,846 |
$84,266.04 |
0.45% |
Ultragenyx Pharmaceutical Inc. |
RARE |
90400D108 |
Biotechnology |
1,736 |
$78,224.16 |
0.42% |
Exact Sciences Corporation |
EXAS |
30063P105 |
Biotechnology |
1,560 |
$75,441.60 |
0.40% |
Viking Therapeutics, Inc. |
VKTX |
92686J106 |
Biotechnology |
1,164 |
$75,287.52 |
0.40% |
Beam Therapeutics Inc. |
BEAM |
07373V105 |
Biotechnology |
2,272 |
$73,090.24 |
0.39% |
ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
3,862 |
$71,640.10 |
0.38% |
CRISPR Therapeutics AG |
CRSP |
H17182108 |
Biotechnology |
1,066 |
$61,369.62 |
0.33% |
Arvinas, Inc. |
ARVN |
04335A105 |
Biotechnology |
1,952 |
$57,623.04 |
0.31% |
US Dollar |
$USD |
|
Other |
50,915 |
$50,915.04 |
0.27% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|